ICA Group Wealth Management’s Novo Nordisk NVO Stock Holding History

ICA Group Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$121K	Buy	850 +62	+8%	+$8.22K	0.07%	153
2024 Q1	$101K	Buy	788 +701	+806%	+$83.4K	0.02%	397
2023 Q4	$9K	Buy	+87	New	+$8.6K	﹤0.01%	896
2023 Q3	–	Sell	-152	Closed	-$12.3K	–	870
2023 Q2	$12.3K	Sell	152 -588	-79%	-$48K	﹤0.01%	802
2023 Q1	$58.9K	Buy	740 +28	+4%	+$1.99K	0.01%	453
2022 Q4	$48.2K	Sell	712 -5,082	-88%	-$298K	0.01%	525
2022 Q3	$289K	Sell	5,794 -142	-2%	-$7.61K	0.06%	266
2022 Q2	$310K	Buy	+5,936	New	+$329K	0.06%	279

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

ICA Group Wealth Management's NVO Position: Q2 2024 in Review

ICA Group Wealth Management increased its Novo Nordisk (NVO) stake by 7.9% in Q2 2024, buying an estimated $8.22K and bringing the position to 850 shares worth $121K. The position accounts for 0.07% of the portfolio, ranked #153.

ICA Group Wealth Management first reported a position in NVO in Q2 2022 and has held it in 8 quarters since. The position peaked at $310K in Q2 2022. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

ICA Group Wealth Management held 850 shares of Novo Nordisk worth $121K as of Q2 2024.
ICA Group Wealth Management bought 62 Novo Nordisk shares in Q2 2024, an estimated $8.22K.
Novo Nordisk made up 0.07% of ICA Group Wealth Management's portfolio in Q2 2024, its #153 holding.
ICA Group Wealth Management first reported a position in Novo Nordisk in Q2 2022 and has held it in 8 quarters since.
ICA Group Wealth Management's Novo Nordisk position peaked at $310K in Q2 2022.
1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.